Becoming pregnant after 35 brings many of the same joys and questions as pregnancy at any age—but it also tends to come with additional conversations about prenatal testing. If your healthcare provider has mentioned genetic screening or diagnostic tests, or if you’re simply trying to understand what options exist before you conceive, you’re in good company. Many women find that having a clear understanding of what these tests do—and what they don’t do—helps them feel more prepared for conversations with their care team.
It’s important to approach this topic with both information and equanimity. The majority of pregnancies after 35 are healthy, and prenatal genetic testing is offered as a tool for information and decision-making—not as an indication that something is wrong. Understanding your options puts you in a position to make choices that align with your values and circumstances, in partnership with your OB/GYN or maternal-fetal medicine specialist.
This overview covers the main categories of prenatal genetic testing available, what they test for, and the kinds of questions worth bringing to your healthcare provider. Individual risk factors, personal preferences, and clinical recommendations vary, so all decisions about testing are best made in consultation with your care team.
What Research Shows About Age and Chromosomal Risk
According to the American College of Obstetricians and Gynecologists (ACOG), the risk of certain chromosomal variations, including Down syndrome (trisomy 21), increases with maternal age. At age 35, the likelihood of a pregnancy affected by Down syndrome is approximately 1 in 350; by age 40, that figure rises to approximately 1 in 100. These numbers provide statistical context—they also mean that the large majority of pregnancies at any of these ages are unaffected.
ACOG recommends that prenatal genetic screening and diagnostic testing be offered to all pregnant women, regardless of age, with the understanding that each woman can make her own informed decision about whether and which tests to pursue. Age 35 is no longer considered a hard threshold for mandatory testing—it’s one factor among many in a nuanced conversation.
Screening Tests: Providing Probabilities
Screening tests estimate the statistical likelihood that a pregnancy may be affected by certain chromosomal conditions. They do not provide a diagnosis—a positive or high-risk screening result indicates that further evaluation may be appropriate, not that a condition is present.
Cell-Free DNA Screening (NIPT)
Non-invasive prenatal testing (NIPT), also called cell-free DNA screening, analyzes fragments of placental DNA circulating in the mother’s bloodstream. It can be performed from around 10 weeks of pregnancy and screens for chromosomal conditions including trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), trisomy 13 (Patau syndrome), and sex chromosome variations. NIPT has relatively high sensitivity and specificity, particularly for trisomy 21, but it remains a screening—not diagnostic—test. Positive results are typically followed by diagnostic confirmation.
First Trimester Combined Screening
This approach combines a nuchal translucency ultrasound (measuring fluid at the back of the baby’s neck) with blood tests measuring pregnancy-associated plasma protein-A (PAPP-A) and human chorionic gonadotropin (hCG). When performed between 11 and 14 weeks, this combined approach can estimate risk for certain chromosomal conditions. It is widely available and does not carry procedural risks.
Second Trimester Maternal Serum Screening
Often called the “quad screen,” this blood test measures four substances (AFP, hCG, estriol, and inhibin A) to estimate risk for Down syndrome, trisomy 18, and neural tube defects. It is typically offered between 15 and 20 weeks and may be used alone or in combination with first trimester screening.
Diagnostic Tests: Providing Definitive Answers
Unlike screening tests, diagnostic tests analyze fetal chromosomes directly and can provide a definitive answer about whether a chromosomal condition is present. They carry a small procedural risk and are typically offered when screening results indicate elevated risk, when there is a family history of certain genetic conditions, or when a woman prefers a definitive answer regardless of screening results.
Chorionic Villus Sampling (CVS)
CVS involves taking a small sample of placental tissue, typically between 10 and 13 weeks of pregnancy. The sample can be analyzed for chromosomal conditions and some single-gene disorders. CVS carries a small risk of pregnancy loss—generally estimated at less than 1%—that varies by provider experience and clinical setting.
Amniocentesis
Amniocentesis involves sampling a small amount of amniotic fluid, typically between 15 and 20 weeks. It can detect chromosomal abnormalities and certain genetic conditions with high accuracy. Like CVS, it carries a small procedural risk that your healthcare provider can discuss in the context of your individual situation.
Women who are preparing for pregnancy after 35 often find it helpful to discuss these options with a genetic counselor before or early in pregnancy, so they can make informed decisions about which tests, if any, align with their values and circumstances.
Working With a Genetic Counselor
Genetic counselors are healthcare professionals who specialize in helping individuals and families understand genetic information and navigate testing decisions. For many women, meeting with a genetic counselor—either before pregnancy or in early pregnancy—provides a valuable opportunity to ask detailed questions, understand statistical risk in context, and think through the implications of various testing pathways.
Many maternal-fetal medicine practices include genetic counseling as a standard part of prenatal care, and referrals can typically be made through your OB/GYN. For women with a personal or family history of genetic conditions, this consultation is particularly valuable.
Making Decisions That Align With Your Values
One of the most important things to understand about prenatal genetic testing is that there is no universally “right” choice. Some women prefer comprehensive testing because having information—whatever it reveals—helps them feel prepared. Others prefer to limit testing because they know they would continue the pregnancy regardless of results, or because the anxiety associated with uncertain screening results doesn’t feel worthwhile to them.
Both approaches are valid. For women exploring the emotional aspects of pregnancy after 35, understanding that testing decisions are personal—and that healthcare providers should support informed choice rather than prescribing a specific path—can itself be reassuring.
Frequently Asked Questions
Is prenatal genetic testing mandatory after 35?
No. ACOG recommends that prenatal genetic screening and diagnostic options be offered and discussed with all pregnant women, but the decision to pursue testing is personal and voluntary. Your healthcare provider should provide information and support your individual decision, whatever it is.
What’s the difference between screening and diagnostic testing?
Screening tests estimate the statistical likelihood of certain chromosomal conditions—they provide a risk probability, not a diagnosis. Diagnostic tests, such as CVS or amniocentesis, analyze fetal chromosomes directly and can provide a definitive answer, but carry a small procedural risk that screening tests do not.
When in pregnancy are these tests performed?
NIPT and CVS are typically performed in the first trimester (from around 10 weeks). First trimester combined screening is performed between 11 and 14 weeks. Second trimester screening and amniocentesis are generally offered between 15 and 20 weeks. Your OB/GYN or midwife will help you understand timing in the context of your pregnancy.
What happens if a screening test comes back high-risk?
A high-risk screening result indicates that the statistical probability of a chromosomal condition is elevated compared to baseline—it does not mean a condition is present. Your healthcare provider will typically recommend a consultation with a genetic counselor and discuss options for diagnostic testing to obtain more definitive information.
Key Takeaways
- Prenatal genetic testing options include both screening tests (which estimate risk probability) and diagnostic tests (which provide definitive chromosomal information); each has different timing, accuracy, and risk profiles.
- ACOG recommends these options be discussed with all pregnant women, regardless of age, and decisions are personal rather than medically mandated.
- A genetic counselor can be a valuable resource for understanding test options, interpreting results, and navigating decisions that align with individual values.
- The majority of pregnancies after 35 are healthy—these tests are tools for information and preparedness, not indicators that something is wrong.
- All testing decisions should be made in close partnership with your healthcare provider based on your individual risk factors, preferences, and circumstances.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.